1. Home
  2. TAK vs OTIS Comparison

TAK vs OTIS Comparison

Compare TAK & OTIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • OTIS
  • Stock Information
  • Founded
  • TAK 1781
  • OTIS 1853
  • Country
  • TAK Japan
  • OTIS United States
  • Employees
  • TAK N/A
  • OTIS N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • OTIS Consumer Electronics/Appliances
  • Sector
  • TAK Health Care
  • OTIS Technology
  • Exchange
  • TAK Nasdaq
  • OTIS Nasdaq
  • Market Cap
  • TAK 42.2B
  • OTIS 37.7B
  • IPO Year
  • TAK N/A
  • OTIS N/A
  • Fundamental
  • Price
  • TAK $14.71
  • OTIS $98.52
  • Analyst Decision
  • TAK
  • OTIS Hold
  • Analyst Count
  • TAK 0
  • OTIS 7
  • Target Price
  • TAK N/A
  • OTIS $101.00
  • AVG Volume (30 Days)
  • TAK 2.5M
  • OTIS 2.9M
  • Earning Date
  • TAK 05-08-2025
  • OTIS 04-23-2025
  • Dividend Yield
  • TAK 4.01%
  • OTIS 1.58%
  • EPS Growth
  • TAK 15.39
  • OTIS 20.06
  • EPS
  • TAK 0.83
  • OTIS 4.07
  • Revenue
  • TAK $29,124,927,177.00
  • OTIS $14,261,000,000.00
  • Revenue This Year
  • TAK $8.53
  • OTIS $3.56
  • Revenue Next Year
  • TAK N/A
  • OTIS $4.12
  • P/E Ratio
  • TAK $34.69
  • OTIS $24.21
  • Revenue Growth
  • TAK 9.83
  • OTIS 0.37
  • 52 Week Low
  • TAK $12.58
  • OTIS $89.70
  • 52 Week High
  • TAK $15.37
  • OTIS $106.83
  • Technical
  • Relative Strength Index (RSI)
  • TAK 52.69
  • OTIS 49.62
  • Support Level
  • TAK $13.60
  • OTIS $96.41
  • Resistance Level
  • TAK $15.37
  • OTIS $99.72
  • Average True Range (ATR)
  • TAK 0.33
  • OTIS 3.43
  • MACD
  • TAK -0.03
  • OTIS -0.09
  • Stochastic Oscillator
  • TAK 62.71
  • OTIS 54.28

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About OTIS Otis Worldwide Corporation

Otis Worldwide Corp is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis' founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.

Share on Social Networks: